text
"['\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2021년 06월 30일\n)\n(단위 : 천원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\nA&G Pharmaceutical, Inc\n비상장\n2006.07.14\n단순투자\n2,676,548\n987,889\n16.51\n116,349\n-\n-\n-\n987,889\xa0\n16.51\n116,349\n2,912,601\n1,062,859\n셀트리온 유럽\n비상장\n2009.07.21\n경영참여\n2\n1\n100.00\n2\n-\n-\n-\n1\xa0\n100.00\n2\n2\n-\n바이오톡스텍\n상장\n2009.07.28\n단순투자\n2,025,000\n1,631,134\n11.15\n24,793,236\n-\n-\n-5,953,639\n1,631,134\xa0\n11.12\n18,839,597\n63,705,372\n2,016,035\n보스톤 인큐베이션투자조합\n비상장\n2009.11.27\n일반투자\n2,500,000\n11\n25.00\n83,007\n-\n-\n-\n11\xa0\n25.00\n83,007\n336,194\n-2,342\n제이티비씨\n비상장\n2017.09.20\n단순투자\n500,000\n100,000\n0.09\n33,940\n-\n-\n34,046\n100,000\xa0\n0.09\n67,986\n401,083,935\n-25,497,001\n프리미어 글로벌 이노베이션 1호\n비상장\n2017.06.15\n단순투자\n250,000\n3,445\n6.67\n3,444,767\n-393\n-393,334\n-\n3,051\xa0\n6.67\n3,051,433\n99,189,160\n24,256,551\n프리미어 글로벌 이노베이션 2호\n비상장\n2020.11.05\n단순투자\n250,000\n250\n5.56\n250,000\n1,150\n1,150,000\n-\n1,400\xa0\n5.56\n1,400,000\n4,500,138\n-188,067\n매일방송\n비상장\n2011.03.17\n단순투자\n1,000,000\n250,981\n0.48\n1,475,167\n-\n-\n-\n250,981\xa0\n0.48\n1,475,167\n393,311,270\n1,890,589\n뉴스1\n비상장\n2011.06.09\n단순투자\n500,000\n60,000\n5.00\n300,000\n-\n-\n-\n60,000\xa0\n5.00\n300,000\n22,282,973\n2,335,332\n셀트리온제약\n상장\n2013.04.23\n경영참여\n50,057,259\n19,682,190\n54.96\n255,342,176\n393,643\n-\n-\n20,075,833\xa0\n54.93\n255,342,176\n548,074,598\n20,936,032\n2014 성장사다리-IMM 벤처펀드\n비상장\n2014.08.11\n일반투자\n2,000,000\n2,500\n20.00\n1,683,844\n-\n-\n-\n2,500\xa0\n20.00\n1,683,844\n9,083,445\n-1,724,638\n미래에셋 셀트리온신성장 투자조합 1호\n비상장\n2017.03.31\n일반투자\n6,250,000\n425\n50.00\n42,500,000\n100\n10,000,000\n-\n525\xa0\n50.00\n52,500,000\n92,202,238\n1,646,447\nCelltrion Global Safety Data Center\n비상장\n2018.05.23\n경영참여\n1,106,930\n580,563\n99.99\n1,204,581\n-\n-\n-\n580,563\xa0\n99.99\n1,204,581\n1,896,634\n200,712\nCelltrion USA, Inc.\n비상장\n2018.07.24\n경영참여\n38,973\n3,050\n100.00\n6,951,601\n-\n-\n-\n3,050\xa0\n100\n6,951,601\n12,816,032\n-8,632,880\nCelltrion Group Hongkong ltd\n비상장\n2019.04.01\n경영참여\n5,680,500\n7,023,270\n70.00\n8,086,365\n-\n-\n-\n7,023,270\xa0\n70.00\n8,086,365\n29,554,539\n-547,241\n셀트리온충북대 바이오메딕스\n비상장\n2018.07.18\n경영참여\n100,000\n20,000\n50.00\n100,000\n-\n-\n-\n20,000\xa0\n50.00\n100,000\n152,990\n-15,974\nIksuda Therapeutics Limited\n비상장\n2021.06.01\n경영참여\n9,031,863\n-\n-\n-\n717,112\n9,031,863\n-\n717,112\xa0\n19.41\n9,031,863\n3,672,337\n-5,870,059\nCelltrion Asia Pacific PTE\n비상장\n2020.11.23\n경영참여\n315,987,120\n283,600,000\n100.00\n315,987,120\n-\n-\n-\n283,600,000\xa0\n100.00\n315,987,120\n325,408,677\n-3,294,286\n합 계\n313,945,709\n-\n662,352,155\n1,111,612\n19,788,529\n-5,919,593\n315,057,320\xa0\n-\n676,221,091\n2,010,183,135\n8,572,069\n']"
